The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas
- 1 January 1985
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 11 (1), 31-36
- https://doi.org/10.1016/0360-3016(85)90359-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.Journal of Clinical Oncology, 1983
- Splenectomy in Hodgkinʼs diseaseAmerican Journal of Clinical Oncology, 1982
- Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphomaBlood, 1976
- Splenectomy for hematologic depression in lymphocytic lymphoma and leukemiaCancer, 1975
- The role of splenectomy in the management of advanced hodgkin's diseaseCancer, 1974
- Splenectomy Effects on Chemotherapy in Hodgkin's DiseaseArchives of Internal Medicine, 1973
- Effect of prior splenectomy on hematologic tolerance during total lymphoid radiotherapy of patients with Hodgkin's diseaseCancer, 1971
- Splenectomy in Hodgkin's disease for splenomegaly, cytopenias and intolerance to myelosuppressive chemotherapyAmerican Journal Of Medicine, 1971
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970